Skip to main content
Caplight Logo









OncoAI

OncoAI

Private
São PauloHealthcare & Life Scienceshttps://oncoai.com.br/

Last Round

Grant

Feb 1, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

OncoAI operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a Grant round in February 2026.

OncoAI is a healthcare technology company that operates an AI-powered platform for cancer prediction, monitoring, and clinical decision support.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Precision Medicine, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

OncoAI Comparables

Compare OncoAI with similar companies based on industry and business-model similarity.

OncoAI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OTAWA Health
77%
RT Medical Systems
69%
Roche Holding
68%
Book a demo to see all comparables

For institutional investors. Book with your work email.

OncoAI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

OncoAI Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 84% MoM.

  • Jul 25, 2026

    Monthly visitors increased 54% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

OncoAI Filings

Explore SEC and related filing metadata, where available.

OncoAI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about OncoAI's valuation, stock price, and market status.

Is OncoAI a public or private company?

OncoAI is a private company.

What is the current stock price of OncoAI?

OncoAI is a private company, so its shares have no public market price. Caplight tracks OncoAI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is OncoAI worth (valuation)?

Valuation information for OncoAI is not publicly available.

Can I buy OncoAI stock?

OncoAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was OncoAI's last funding round?

OncoAI's most recent funding round was Grant on February 1, 2026.

Who are the main investors in OncoAI?

Key investors in OncoAI include Japan International Cooperation Agency, B Venture Capital, Canastra Ventures, Bayer Cares Foundation.

Will OncoAI IPO soon?

No public IPO plans have been announced for OncoAI.

How can I track OncoAI secondary market activity?

Caplight tracks bids, offers, and trades in OncoAI's shares on secondary markets.

Firmographic Details

HeadquartersSão Paulo
Employee Range3
Year Founded2023
Last FundingFeb 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?